Tech Stock News
Sunday, September 25, 2022
BriaCell Therapeutics Corp (NASDAQ: BCTX) jumped 6.51% after the company announced its targeted oncology therapy advancement into other novel immunotherapy cell lines: Bria-Mel for melanoma Bria-lung for lung cancer, and Bria-Pros from Prostate cancer. BriaCell developing personalized cancer immunotherapies The company’s immunotherapy treatment seemed to be effective in breast cancer […]
BriaCell Therapeutics Corp. (NASDAQ: BCTX), the clinical-stage biotechnology company, recently reported the overall survival benefit of its ongoing advanced breast cancer study. The company released overall survival (OS) data of women under treatment of Bria-IMT™, the company’s lead candidate for monotherapy in breast cancer. Bria-IMT™ is used alongside checkpoint inhibitors […]